4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-022432
Chief Operating Officer sold 4,400 shares at an average $16.07 ($70,729)
- Chief Operating Officer acquired 4,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2023-03-30 | Option exercise 10b5-1 | +2,000 | $0.61 | $1,220 | 529,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-03-30 | Sale 10b5-1 | −2,000 | $16.01 | $32,015 | 527,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-03-31 | Option exercise 10b5-1 | +400 | $0.61 | $244 | 528,381 | D |
| Bensen Daniel Chief Operating Officer | 2023-03-31 | Sale 10b5-1 | −400 | $16.00 | $6,400 | 527,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-04-03 | Option exercise 10b5-1 | +2,000 | $0.61 | $1,220 | 529,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-04-03 | Sale 10b5-1 | −2,000 | $16.16 | $32,314 | 527,981 | D |
| Derivatives | |||||||
| Bensen Daniel Chief Operating Officer | 2023-03-30 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 231,821 | D | ||
| Bensen Daniel Chief Operating Officer | 2023-03-31 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −400 | 231,421 | D | ||
| Bensen Daniel Chief Operating Officer | 2023-04-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 229,421 | D | ||
| Open-market sales · 4,400 sh · avg $16.07 · $70,729 | |||||||
Loading xslF345X04/doc4.xml…